Lung Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men.
|
22072123 |
2012 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis.
|
17900751 |
2008 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer.
|
18415801 |
2008 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations.
|
18463401 |
2008 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Prospective study of urinary excretion of 7-methylguanine and the risk of lung cancer: Effect modification by mu class glutathione-S-transferases.
|
17565746 |
2007 |
Lung Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
|
17311802 |
2007 |
Lung Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
|
17114358 |
2007 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
|
16009381 |
2005 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
|
16228113 |
2005 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
CYP1A1 and GSTM1 genetic polymorphisms in lung cancer populations exposed to arsenic in drinking water.
|
16012082 |
2005 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
|
14534704 |
2004 |
Lung Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Interpretation of genetic risk feedback among African American smokers with low socioeconomic status.
|
15008663 |
2004 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition.
|
14628089 |
2003 |
Lung Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
GSTM1 and GSTT1 polymorphisms, tobacco and risk of lung cancer: a case-control study from Galicia, Spain.
|
14666648 |
2003 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
|
12814998 |
2003 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Strong association between the GSTM1-null genotype and lung cancer in a Turkish population.
|
14553946 |
2003 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility.
|
12189190 |
2002 |
Lung Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Can't lung cancer patients detoxify procarcinogens?
|
11939169 |
2002 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study.
|
12376472 |
2002 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
LHGDN |
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.
|
12151353 |
2002 |
Lung Neoplasms
|
0.400 |
Biomarker
|
group |
LHGDN |
Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes.
|
11844594 |
2002 |
Lung Neoplasms
|
0.400 |
GeneticVariation
|
group |
BEFREE |
In patients with inducible CYP1A1, the expressing GSTM1 gene appeared to have a protective effect against contracting bronchial lung cancer, since 88% (14/16) of the lung tumours in this patient group were peripheral, whereas almost equal numbers of peripheral and bronchial tumours were observed in those patients lacking the gene (P = 0.037).
|
8020145 |
1994 |